These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 26243735)

  • 81. Real-world switch patterns and healthcare costs in biologic-naive psoriasis patients initiating apremilast or biologics.
    Wu JJ; Pelletier C; Ung B; Tian M; Khilfeh I; Curtis JR
    J Comp Eff Res; 2020 Aug; 9(11):767-779. PubMed ID: 32638609
    [No Abstract]   [Full Text] [Related]  

  • 82. Apremilast Normalizes Gene Expression of Inflammatory Mediators in Human Keratinocytes and Reduces Antigen-Induced Atopic Dermatitis in Mice.
    Schafer PH; Adams M; Horan G; Truzzi F; Marconi A; Pincelli C
    Drugs R D; 2019 Dec; 19(4):329-338. PubMed ID: 31598889
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Longterm (52-week) results of a phase III randomized, controlled trial of apremilast in patients with psoriatic arthritis.
    Kavanaugh A; Mease PJ; Gomez-Reino JJ; Adebajo AO; Wollenhaupt J; Gladman DD; Hochfeld M; Teng LL; Schett G; Lespessailles E; Hall S
    J Rheumatol; 2015 Mar; 42(3):479-88. PubMed ID: 25593233
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Oral small molecules for psoriasis.
    Singh S; Armstrong AW
    Semin Cutan Med Surg; 2018 Sep; 37(3):163-166. PubMed ID: 30215633
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Phosphodiesterase 4 in inflammatory diseases: Effects of apremilast in psoriatic blood and in dermal myofibroblasts through the PDE4/CD271 complex.
    Schafer PH; Truzzi F; Parton A; Wu L; Kosek J; Zhang LH; Horan G; Saltari A; Quadri M; Lotti R; Marconi A; Pincelli C
    Cell Signal; 2016 Jul; 28(7):753-63. PubMed ID: 26806620
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Apremilast mechanism of efficacy in systemic-naive patients with moderate plaque psoriasis: Pharmacodynamic results from the UNVEIL study.
    Strober B; Alikhan A; Lockshin B; Shi R; Cirulli J; Schafer P
    J Dermatol Sci; 2019 Dec; 96(3):126-133. PubMed ID: 31787506
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Apremilast: A Novel Drug for Treatment of Psoriasis and Psoriatic Arthritis.
    Haber SL; Hamilton S; Bank M; Leong SY; Pierce E
    Ann Pharmacother; 2016 Apr; 50(4):282-90. PubMed ID: 26783350
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Apremilast: A Review in Oral Ulcers of Behçet's Disease.
    Deeks ED
    Drugs; 2020 Feb; 80(2):181-188. PubMed ID: 31933168
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Phosphodiesterase 4 Inhibitors in Immune-mediated Diseases: Mode of Action, Clinical Applications, Current and Future Perspectives.
    Sakkas LI; Mavropoulos A; Bogdanos DP
    Curr Med Chem; 2017; 24(28):3054-3067. PubMed ID: 28554321
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Efficacy of tyrosine-kinase-2 and phosphodiesterase-4 inhibitors for scalp psoriasis: a systematic review and meta-analysis.
    Tsiogkas SG; Karamitrou EK; Grammatikopoulou MG; Zafiriou E; Bogdanos DP
    Curr Med Res Opin; 2024 Feb; 40(2):155-163. PubMed ID: 37997745
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Real-world data on the efficacy and safety of apremilast in Japanese patients with plaque psoriasis.
    Ohata C; Ohyama B; Kuwahara F; Katayama E; Nakama T
    J Dermatolog Treat; 2019 Jun; 30(4):383-386. PubMed ID: 30221571
    [No Abstract]   [Full Text] [Related]  

  • 92. Real-World Experience With Apremilast in the Treatment of Adults With Moderate to Severe Plaque Psoriasis in Québec: A Claims-Based Analysis of Drug Utilization and Healthcare Resource Utilization.
    Poulin Y; Beauchemin C; Royer C; Gaudreau AJ; Yim C; Liu FF; Lachaine J
    J Cutan Med Surg; 2020; 24(6):573-587. PubMed ID: 32597685
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Apremilast, an oral phosphodiesterase 4 inhibitor, in patients with psoriatic arthritis and current skin involvement: a phase III, randomised, controlled trial (PALACE 3).
    Edwards CJ; Blanco FJ; Crowley J; Birbara CA; Jaworski J; Aelion J; Stevens RM; Vessey A; Zhan X; Bird P
    Ann Rheum Dis; 2016 Jun; 75(6):1065-73. PubMed ID: 26792812
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Open-Label Study to Evaluate the Efficacy of Etanercept Treatment in Subjects With Moderate to Severe Plaque Psoriasis Who Have Failed Therapy With Apremilast.
    Bagel J; Samad AS; Stolshek BS; Aras GA; Chung JB; Kricorian G; Kircik LH
    J Drugs Dermatol; 2018 Oct; 17(10):1078-1082. PubMed ID: 30365588
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Apremilast and Narrowband Ultraviolet-B Combination Therapy for Treating Moderate-to-Severe Plaque Psoriasis.
    Bagel J; Nelson E; Keegan BR
    J Drugs Dermatol; 2017 Oct; 16(10):957-962. PubMed ID: 29036248
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Trial watch: PDE4 inhibitor leads wave of target-specific oral psoriasis drugs.
    Harrison C
    Nat Rev Drug Discov; 2013 May; 12(5):335. PubMed ID: 23629496
    [No Abstract]   [Full Text] [Related]  

  • 97. Chronic tearing induced by apremilast.
    Norris MR; Bielory L
    Ann Allergy Asthma Immunol; 2018 Sep; 121(3):375. PubMed ID: 29969663
    [No Abstract]   [Full Text] [Related]  

  • 98. Apremilast in psoriasis - a prospective real-world study.
    Vujic I; Herman R; Sanlorenzo M; Posch C; Monshi B; Rappersberger K; Richter L
    J Eur Acad Dermatol Venereol; 2018 Feb; 32(2):254-259. PubMed ID: 28925560
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Apremilast is effective in controlling the progression of adult vitiligo: A case series.
    Majid I; Imran S; Batool S
    Dermatol Ther; 2019 Jul; 32(4):e12923. PubMed ID: 30977956
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Long-Term Effectiveness and Drug Survival of Apremilast in Treating Psoriasis: A Real-World Experience.
    Distel J; Cazzaniga S; Seyed Jafari SM; Emelianov V; Schlapbach C; Yawalkar N; Heidemeyer K
    Dermatology; 2022; 238(2):267-275. PubMed ID: 34091455
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.